Summary

The global clinical informatics market is projected to reach 563.18 billion by 2030 from 231.45 billion in 2024, at a CAGR of 16.0% from 2024 to 2030. The growth of the Clinical Informatics market is driven by growing Hospital-Acquired Infections, or HAIs. Hospital-acquired infections lead to severe health issues and eventually death in many patients during their stay in hospitals. Some of the common forms of HAI's are as follows; bloodstream infections urinary tract infection, pneumonia, C. Difficile infections are highly prevalent in hospitals. The 2023 National and State Healthcare-Associated Infections (HAI) Progress Report shows that all the healthcare settings, from acute care hospitals to inpatient rehabilitation facilities and long-term acute care hospitals, have positive trends in decreasing healthcare-associated infections. In the US, the report shows that significant infections declined compared to 2022, including a 13% decline in CLABSI, an 11% decline in CAUTI, and a 5% decline in VAE. The increased adoption of EHRs also facilitates access to data and stimulates the need for more complex clinical informatics solutions. Moreover, rising chronical diseases such as cardiovascular diseases, obesity, and diabetes are the growth factors of the clinical informatics market.
“The telehealth solutions segment is projected to be the largest segment in the clinical clinical informatics market”
Based on the function segment, the telehealth solutions segment is projected to be the largest segment during the forecast period largely because of the changes brought on by the COVID-19 pandemic. A recent survey by Public Opinion Strategies for hims & hers in January 2024 found that 54% of Americans have used telehealth, with 89% of those users expressing satisfaction with their experience. This satisfaction rate has remained well over the past four years. Moreover, many Americans aware of the weight loss drug, such as Ozempic, support letting telehealth physicians prescribe the medications. Telehealth around the world for the government also works to increase growth in the clinical informatics market. There is also motivation through the WHO Global Strategy on Digital Health 2020-2025, Sláintecare Action Plan, HSE Corporate Plan, and Healthy Ireland government programs. This led to an increased need for enhancing the quality of care and the growing mergers of healthcare providers and more adoption of digital and connected healthcare technologies. consolidation among healthcare providers, and the rising adoption of digital and connected healthcare technologies.

“Cloud based deployment is the fastest segment in the clinical informatics market in 2023”
Cloud-based deployment is forecasted to be the fastest-growing part in the clinical informatics market in 2023, because this model has various benefits such as easy data integration from different cloud sources, unlimited access for users from remote places, low maintenance costs, high security, privacy, easy access, no need to buy hardware upfront, and great flexibility in capacity and resource use. Many applications offered by the cloud-based model, which cover accounting, performance monitoring, and communication through webmail and instant messaging, are helping this segment grow.
“APAC to witness the highest growth rate during the forecast period.”
The clinical informatics market is categorized into regions including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Of these, the Asia Pacific (APAC) region is expected to see the highest growth rate in the forecast periods. Market growth in the APAC region is mainly driven by factors such as the improving healthcare infrastructure, adoption of technology solutions and government initiatives for the adoption of clinical informatics solutions. For instance, the recent initiatives by the National Accreditation Board for Hospitals (NABH) to establish standards and guidelines for Hospital Information Systems (HIS) and Electronic Medical Records (EMR) are significantly driving the demand for healthcare technology solutions in India. Since launching these digital health standards in September 2023, 275 hospitals have already applied for certification, with 100 of them achieving it. This regulatory push is not only boosting the demand for clinical informatics solutions but is also helping India improve its healthcare delivery through better digital infrastructure.

The break-down of primary participants is as mentioned below:
• By Company Type - Tier 1: 45%, Tier 2: 35%, and Tier 3: 20%
• By Designation - C-level: 35%, Director-level: 25%, and Others: 40%
• By Region - North America: 45%, Europe: 30%, Asia Pacific: 20%, Latin America: 3%, and Middle East & Africa: 2%.
UnitedHealth Group. (US), Koninklijke Philips N.V. (Netherlands), and GE Healthcare (US) are some of the key players in the clinical informatics market.
• The study includes an in-depth competitive analysis of these key players in the clinical informatics market, with their company profiles, recent developments, and key market strategies.

Research Coverage
This research report categorizes the clinical informatics market by function (EHR, practice management systems, clinical workflow management, diagnostic and imaging solutions, clinical decision support systems, patient monitoring software, medication management, treatment focused specialty information system, telehealth & telemedicine, infection surveillance solutions, patient portals & patient engagement, population health management, data analytics and reporting solutions, mobile health applications, and HCIT integration & interoperability systems), by therapeutic area (oncology, cardiology, neurology, respiratory diseases, immunology, metabolic disorders, infectious diseases, and others (nephrology, urology, rare disease, hematology, gastroenterology, dermatology, ophthalmology, endocrinology, musculoskeletal disorders, mental health, and others), by component (software and services), by deployment (cloud based model, on premises model and hybrid model), by end users (hospitals, ambulatory surgical centers, ambulatory care centers, and other outpatient settings, specialty care centers, home healthcare, long-term care, & assisted living facilities, diagnostic & imaging centers, pharmacies, others (accountable care organization, management care organizations, and others) ),and by region (North America, Europe, Asia Pacific, Latin America, and Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the clinical informatics market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; Contracts, partnerships, agreements. new product & service launches, mergers and acquisitions, and recent developments associated with the clinical informatics market. Competitive analysis of upcoming startups in the clinical informatics market ecosystem is covered in this report.
Reasons to buy this report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the clinical informatics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
• Analysis of key drivers (growing telehealth and remote patient monitoring markets, government support for adopting it solutions, rising healthcare cost, increase in the adoption of ehr, growing pressure to reduce healthcare spending, and increase in demand for data driven decision making) restraints (complexity of big data in healthcare and lack of interoperability) opportunities (adavancement in real time data analysis, growth of mobile health (mhealth), growth of precision medicine & genomics, shift to value based care, growth of clincials assistants and rising economies of emerging countries)challenges (shortage of skilled it professionals and increasing number of data security issues) influencing the growth of the clinical informatics market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the clinical informatics market
• Market Development: Comprehensive information about lucrative markets – the report analyses the clinical informatics market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the clinical informatics market
• Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like UnitedHealth Group (US), Koninklijke Philips N.V. (Netherlands), GE HealthCare (US), Cognizant (US), Oracle (US), Epic Systems Corporation. (US); among others in the clinical informatics market

ページTOPに戻る

Table of Contents

1 INTRODUCTION 41
1.1 STUDY OBJECTIVES 41
1.2 MARKET DEFINITION 41
1.3 STUDY SCOPE 42
1.3.1 SEGMENTS CONSIDERED & GEOGRAPHICAL SPREAD 42
1.3.2 INCLUSIONS & EXCLUSIONS 43
1.3.3 YEARS CONSIDERED 45
1.3.4 CURRENCY CONSIDERED 45
1.4 STAKEHOLDERS 46
2 RESEARCH METHODOLOGY 47
2.1 RESEARCH DESIGN 47
2.2 RESEARCH DATA 48
2.2.1 SECONDARY DATA 48
2.2.1.1 Key sources for secondary data 48
2.2.1.2 Key data from secondary sources 49
2.2.2 PRIMARY DATA 49
2.2.2.1 Key sources for primary data 50
2.2.2.2 Key objectives of primary research 50
2.2.2.3 Key data from primary sources 51
2.2.2.4 Key industry insights 52
2.2.2.5 Breakdown of primary interviews 52
2.3 MARKET SIZE ESTIMATION 53
2.3.1 SUPPLY-SIDE ANALYSIS 54
2.3.2 BOTTOM-UP APPROACH (END-USER ADOPTION) 56
2.3.3 TOP-DOWN APPROACH 57
2.3.4 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS 57
2.4 DATA TRIANGULATION 61
2.5 RESEARCH ASSUMPTIONS 62
2.5.1 MARKET SIZING ASSUMPTIONS 62
2.5.2 STUDY ASSUMPTIONS 62
2.6 RISK ASSESSMENT 63
2.7 RESEARCH LIMITATIONS 63
2.7.1 METHODOLOGY-RELATED LIMITATIONS 63
2.7.2 SCOPE-RELATED LIMITATIONS 63
3 EXECUTIVE SUMMARY 64
 
4 PREMIUM INSIGHTS 71
4.1 CLINICAL INFORMATICS MARKET OVERVIEW 71
4.2 CLINICAL INFORMATICS MARKET, BY END USER AND REGION 72
4.3 CLINICAL INFORMATICS MARKET: GEOGRAPHIC SNAPSHOT 73
4.4 CLINICAL INFORMATICS MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS 74
5 MARKET OVERVIEW 75
5.1 INTRODUCTION 75
5.2 MARKET DYNAMICS 75
5.2.1 DRIVERS 77
5.2.1.1 Increasing focus on telehealth & remote patient monitoring 77
5.2.1.2 Favorable government initiatives for adoption of IT solutions 79
5.2.1.3 Growing need to curb healthcare spending 80
5.2.1.4 Increasing adoption of EHR 81
5.2.1.5 Growing focus on data-driven decision-making 82
5.2.2 RESTRAINTS 82
5.2.2.1 Interoperability issues associated with information systems 82
5.2.2.2 High deployment costs 83
5.2.2.3 Resistance from conventional healthcare providers 84
5.2.3 OPPORTUNITIES 84
5.2.3.1 Gradual shift toward outpatient care environments 84
5.2.3.2 Potential benefits of real-world evidence 85
5.2.3.3 Development of mHealth tools 86
5.2.3.4 Emergence of precision medicine and utilization of omics data sets 87
5.2.3.5 Emphasis on value-based medicine 88
5.2.3.6 Uptake of virtual clinical & nursing assistants 89
5.2.3.7 High-growth potential of emerging economies 90
5.2.4 CHALLENGES 91
5.2.4.1 Shortage of skilled IT professionals 91
5.2.4.2 Data security concerns 91
5.2.4.3 Complexities associated with big data in healthcare 95
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 95
5.4 INDUSTRY TRENDS 96
5.4.1 INTEROPERABILITY & INTEGRATED CARE MODELS 96
5.4.2 CLOUD-BASED SOLUTIONS 97
5.4.3 BIG DATA IN HEALTHCARE 98
5.5 ECOSYSTEM ANALYSIS 99
5.6 VALUE CHAIN ANALYSIS 102
5.7 TECHNOLOGY ANALYSIS 103
5.7.1 KEY TECHNOLOGIES 103
5.7.1.1 Predictive analytics 103
5.7.1.2 Artificial intelligence & machine learning 104
5.7.1.3 Virtual assistants & chatbots 104
5.7.1.4 Augmented & virtual reality 104
5.7.2 COMPLEMENTARY TECHNOLOGIES 105
5.7.2.1 Real-world evidence data 105
5.7.2.2 EHR-integration 105
5.7.2.3 Digital health platforms 105
5.7.2.4 Clinical data warehousing & big data analytics 106
5.7.2.5 Digital pathology 106
5.7.3 ADJACENT TECHNOLOGIES 107
5.7.3.1 Cloud computing 107
5.7.3.2 Blockchain technology 107
5.7.3.3 IoT & wearables 107
5.7.3.4 Genomics & precision medicine platforms 107
5.8 REGULATORY ANALYSIS 108
5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, & OTHER ORGANIZATIONS 108
5.8.2 REGULATORY SCENARIO 111
5.8.2.1 North America 111
5.8.2.2 Europe 113
5.8.2.3 Asia Pacific 113
5.8.2.4 Middle East & Africa 115
5.8.2.5 Latin America 115
5.9 PRICING ANALYSIS 115
5.9.1 INDICATIVE PRICE OF CLINICAL INFORMATICS SOLUTIONS,
BY FUNCTION (2023) 116
5.9.1.1 Average selling price of EHR solutions, by key player (2023) 116
5.9.1.2 Indicative price of EHR solutions, by component (2023) 117
5.9.1.3 Indicative price of clinical decision support systems, by product (2023) 117
5.9.1.4 Indicative price of HCIT integration solutions, by component (2023) 118
5.9.2 INDICATIVE PRICE OF CLINICAL INFORMATICS SOLUTIONS, BY REGION (2023) 119
5.10 PORTER’S FIVE FORCES ANALYSIS 120
5.10.1 INTENSITY OF COMPETITIVE RIVALRY 122
5.10.2 BARGAINING POWER OF BUYERS 122
5.10.3 THREAT OF SUBSTITUTES 122
5.10.4 THREAT OF NEW ENTRANTS 122
5.10.5 BARGAINING POWER OF SUPPLIERS 122
5.11 KEY STAKEHOLDERS AND BUYING CRITERIA 123
5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS 123
5.11.2 KEY BUYING CRITERIA 124
 
5.12 PATENT ANALYSIS 124
5.12.1 PATENT PUBLICATION TRENDS 124
5.12.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES
FOR CLINICAL INFORMATICS 125
5.12.3 LEADING PATENTS IN CLINICAL INFORMATICS MARKET 127
5.13 END-USER ANALYSIS 130
5.13.1 UNMET NEEDS 130
5.13.2 END-USER EXPECTATIONS 131
5.14 KEY CONFERENCES & EVENTS, 2024–2025 132
5.15 CASE STUDY ANALYSIS 133
5.15.1 TRANSFORMING CLINICAL INFORMATICS AT CORNWALL COMMUNITY HOSPITAL 133
5.15.2 GRANGER MEDICAL CLINIC’S FOCUS ON GAINING EFFICIENT HEALTHCARE OPERATIONS 134
5.15.3 IMPROVEMENTS IN IMAGING EFFICIENCY BY OVERCOMING REPORTING & VISUALIZATION BARRIERS 135
5.16 INVESTMENT & FUNDING SCENARIO 136
5.17 BUSINESS MODELS 136
5.18 IMPACT OF AI/GEN AI IN CLINICAL INFORMATICS MARKET 137
5.18.1 KEY-USE CASES 139
5.18.2 CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION 139
5.18.2.1 Case Study 1: Enhancing diagnostic accuracy with AI solutions at Princess Alexandra Hospital 139
5.18.2.2 Case Study 2: Leveraging AI for proactive infection prevention in hospital 140
5.18.3 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 141
5.18.3.1 Healthcare IT Market 141
5.18.3.2 Clinical decision support system market 141
5.18.3.3 Telehealth & telemedicine market 142
5.18.3.4 Ambulatory EHR market 142
5.18.4 USER READINESS & IMPACT ASSESSMENT 142
5.18.4.1 User readiness 142
5.18.4.1.1 User A: Hospitals 142
5.18.4.1.2 User B: Ambulatory surgery centers 142
5.18.4.2 Impact assessment 143
5.18.4.2.1 User A: Hospitals 143
5.18.4.2.1.1 Implementation 143
5.18.4.2.1.2 Impact 143
5.18.4.2.2 User B: Ambulatory surgery centers 143
5.18.4.2.2.1 Implementation 143
5.18.4.2.2.2 Impact 144
 
6 CLINICAL INFORMATICS MARKET, BY FUNCTION 145
6.1 INTRODUCTION 146
6.2 ELECTRONIC HEALTH RECORDS 148
6.2.1 NEED FOR INTEGRATED HEALTHCARE SYSTEMS TO FUEL UPTAKE 148
6.3 PRACTICE MANAGEMENT SYSTEMS 149
6.3.1 DIGITAL SHIFT IN MEDICAL PRACTICE MANAGEMENT TO SUPPORT ADOPTION IN HEALTHCARE ORGANIZATIONS 149
6.4 CLINICAL WORKFLOW MANAGEMENT SYSTEMS 150
6.4.1 WORKFLOW AUTOMATION SOLUTIONS 151
6.4.1.1 Patient flow management solutions 152
6.4.1.1.1 Patient flow management to improve resource utilization and prevent staff burnout by streamlining workflows 152
6.4.1.2 Clinician & staff scheduling solutions 154
6.4.1.2.1 Need for improved efficiency and reduced scheduling conflicts to augment segment growth 154
6.4.2 CLINICAL COMMUNICATION & COLLABORATION SOLUTIONS 155
6.4.2.1 Advantages in decision-making and process expediency to drive market 155
6.5 DIAGNOSTIC & IMAGING SOLUTIONS 156
6.5.1 MEDICAL IMAGE ANALYSIS SOFTWARE 157
6.5.1.1 Robust growth of 3D medical imaging systems and digitization of measurement values to support segment growth 157
6.5.2 PACS & VNA 158
6.5.2.1 Favorable government initiatives to modernize imaging facilities to spur segment growth 158
6.5.3 RADIOLOGY INFORMATION SYSTEMS 160
6.5.3.1 Focus on healthcare digitization and rising demand for efficient workflow optimization in healthcare facilities to drive segment 160
6.5.4 LABORATORY INFORMATION SYSTEMS 161
6.5.4.1 Rising demand for accurate and efficient lab test results to fuel market growth 161
6.6 CLINICAL DECISION SUPPORT SYSTEMS 162
6.6.1 SUPPORT IN DEVELOPING BETTER TREATMENT PLANS TO DRIVE ADOPTION 162
6.7 MEDICATION MANAGEMENT SYSTEMS 163
6.7.1 EPRESCRIBING SOLUTIONS 165
6.7.1.1 Ability to link and search patient records and easy access to patient information to boost market growth 165
6.7.2 COMPUTERIZED PHYSICIAN ORDER ENTRY SYSTEMS 166
6.7.2.1 Need for minimizing prescription and drug administration errors to drive segment 166
6.7.3 PHARMACY INFORMATION SYSTEMS 167
6.7.3.1 Pharmacy information systems to reduce medication dispensing error rates and ensure efficient inventory control 167
 
6.8 SPECIALTY INFORMATION MANAGEMENT SOLUTIONS 168
6.8.1 ONCOLOGY INFORMATION SYSTEMS 169
6.8.1.1 Rise in cancer prevalence and technological advancements in oncology treatments to support market growth 169
6.8.2 CARDIOVASCULAR INFORMATION SYSTEMS 170
6.8.2.1 Increasing incidence of cardiovascular diseases to
propel market growth 170
6.8.3 OTHER SPECIALITY INFORMATION MANAGEMENT SOLUTIONS 171
6.9 TELEHEALTH & TELEMEDICINE SOLUTIONS 172
6.9.1 SHORTAGE OF HEALTHCARE WORKFORCE AND NEED FOR REMOTE PATIENT MONITORING TO ACCELERATE ADOPTION 172
6.10 INFECTION SURVEILLANCE SOLUTIONS 173
6.10.1 INCREASING PREVALENCE OF HOSPITAL-ACQUIRED INFECTIONS
TO AID MARKET GROWTH 173
6.11 PATIENT PORTALS & ENGAGEMENT SOLUTIONS 174
6.11.1 BETTER PERSONALIZED MEDICATION PLANS AND STREAMLINED FOLLOW-UP CARE TO SUPPORT MARKET GROWTH 174
6.12 POPULATION HEALTH MANAGEMENT SOLUTIONS 175
6.12.1 POPULATION HEALTH MANAGEMENT SOLUTIONS TO REDUCE READMISSIONS AND TRACK CARE ACROSS MULTIPLE SPECIALTIES 175
6.13 DATA ANALYTICS & REPORTING SOLUTIONS 176
6.13.1 NEED FOR ENHANCED PATIENT CARE AND STREAMLINED OPERATIONS TO FUEL UPTAKE 176
6.14 MOBILE HEALTH APPLICATIONS 177
6.14.1 RISING PREFERENCE FOR SELF-CARE MANAGEMENT TO BOOST MARKET GROWTH 177
6.15 HCIT INTEGRATION & INTEROPERABILITY SYSTEMS 178
6.15.1 NEED TO REPLACE OUTDATED MEDICAL TECHNOLOGY AND REDUCE HEALTHCARE COSTS TO PROPEL MARKET GROWTH 178
6.16 OTHER FUNCTIONS 179
7 CLINICAL INFORMATICS MARKET, BY DEPLOYMENT MODEL 181
7.1 INTRODUCTION 182
7.2 CLOUD-BASED MODEL 182
7.2.1 POTENTIAL SCALABILITY AND COST-EFFECTIVENESS TO DRIVE MARKET 182
7.3 ON-PREMISE MODEL 184
7.3.1 GROWING DEMAND FOR SECURITY, CONTROL, AND COMPLIANCE NEEDS TO DRIVE MARKET 184
7.4 HYBRID MODELS 185
7.4.1 RISING ADOPTION OF HYBRID CLOUD MODELS TO ENHANCE INNOVATION, SCALABILITY, AND DATA SECURITY 185
 
8 CLINICAL INFORMATICS MARKET, BY COMPONENT 187
8.1 INTRODUCTION 188
8.2 SOFTWARE 188
8.2.1 STANDALONE SOFTWARE 191
8.2.1.1 Rising focus on data management efficiency to drive market 191
8.2.2 INTEGRATED SOFTWARE 192
8.2.2.1 Ability to create cohesive unification among multiple platforms to fuel uptake 192
8.3 SERVICES 193
8.3.1 RISING REQUIREMENT FOR CONSULTING & IMPLEMENTATION SERVICES
TO DRIVE MARKET 193
9 CLINICAL INFORMATICS MARKET, BY THERAPEUTIC AREA 197
9.1 INTRODUCTION 198
9.2 ONCOLOGY 198
9.2.1 RISING ADOPTION OF ELECTRONIC MEDICAL RECORDS TO DRIVE MARKET 198
9.3 CARDIOLOGY 201
9.3.1 ADVANCES IN AI-ENHANCED DIAGNOSTIC IMAGING AND DECISION SUPPORT TO PROPEL DEMAND 201
9.4 NEUROLOGY 202
9.4.1 CHALLENGES IN TREATING AND RESEARCHING NEUROLOGICAL DISORDERS TO DRIVE ADOPTION 202
9.5 RESPIRATORY DISEASES 203
9.5.1 ADVANCES IN IMAGING SOLUTIONS FOR RESPIRATORY DIAGNOSTICS TO PROPEL MARKET 203
9.6 IMMUNOLOGY 204
9.6.1 POTENTIAL FOR ENHANCING DETECTION AND PERSONALIZED THERAPEUTICS TO PROPEL ADOPTION 204
9.7 METABOLIC DISORDERS 205
9.7.1 RISING INCIDENCE OF DIABETES AND LIVER DISEASES TO DRIVE DEMAND 205
9.8 INFECTIOUS DISEASES 206
9.8.1 NEED TO MANAGE AND REDUCE SPREAD OF INFECTIOUS DISEASES TO SUPPORT MARKET GROWTH 206
9.9 OTHER THERAPEUTIC AREAS 207
10 CLINICAL INFORMATICS MARKET, BY END USER 210
10.1 INTRODUCTION 211
10.2 HOSPITALS 212
10.2.1 IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE FOR DIGITAL INFORMATICS TO DRIVE MARKET 212
10.3 AMBULATORY SURGERY CENTERS, AMBULATORY CARE CENTERS, AND OTHER OUTPATIENT SETTINGS 213
10.3.1 ADVANTAGES OF COST-EFFICIENCY AND RAPID TURNAROUND TIMES TO PROPEL MARKET 213
10.4 SPECIALTY CARE CENTERS 214
10.4.1 INCREASING FOCUS ON PERSONALIZED THERAPEUTICS TO SUPPORT MARKET GROWTH 214
10.5 HOME HEALTHCARE, LONG-TERM CARE, AND ASSISTED LIVING FACILITIES 216
10.5.1 GROWING FOCUS ON TELEHEALTH TO FUEL UPTAKE 216
10.6 DIAGNOSTIC & IMAGING CENTERS 217
10.6.1 INCREASING UPTAKE OF ADVANCED IMAGING DIAGNOSTICS INTEGRATED WITH AI SOLUTIONS TO BOOST DEMAND 217
10.7 PHARMACIES 218
10.7.1 RISING REQUIREMENT FOR ELECTRONIC HEALTH RECORDS TO SUPPORT MARKET GROWTH 218
10.8 OTHER END USERS 220
11 CLINICAL INFORMATICS MARKET, BY REGION 221
11.1 INTRODUCTION 222
11.2 NORTH AMERICA 222
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 224
11.2.2 US 230
11.2.2.1 Vast healthcare infrastructure, reforms, and advancements in digital innovation to ensure strong market share 230
11.2.3 CANADA 237
11.2.3.1 Government investment in health infrastructure and adoption of digital solutions such as EHRs 237
11.3 EUROPE 243
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 243
11.3.2 UK 250
11.3.2.1 Growing digitalization of healthcare infrastructure to drive market 250
11.3.3 GERMANY 255
11.3.3.1 Favorable government initiatives to drive market 255
11.3.4 FRANCE 261
11.3.4.1 Strong government support and digitalization to propel market growth 261
11.3.5 ITALY 266
11.3.5.1 Increasing focus on optimizing healthcare resources to accelerate growth 266
11.3.6 SPAIN 272
11.3.6.1 Rising aging population and growing demand for healthcare to support adoption 272
11.3.7 REST OF EUROPE 277
11.4 ASIA PACIFIC 283
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 283
11.4.2 JAPAN 290
11.4.2.1 Well-established healthcare infrastructure and rapidly evolving mobile healthcare sector to drive growth 290
 
11.4.3 CHINA 295
11.4.3.1 Established healthcare reforms for EMR solutions to drive market 295
11.4.4 INDIA 301
11.4.4.1 Growing adoption of EHR solutions to fuel uptake 301
11.4.5 REST OF ASIA PACIFIC 307
11.5 LATIN AMERICA 313
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 314
11.5.2 BRAZIL 320
11.5.2.1 Brazil to dominate clinical informatics market in Latin America 320
11.5.3 MEXICO 325
11.5.3.1 Rising focus on digital health to boost market growth 325
11.5.4 REST OF LATIN AMERICA 330
11.6 MIDDLE EAST & AFRICA 336
11.6.1 INCREASING INVESTMENTS IN MODERNIZING HEALTHCARE SYSTEMS TO BOOST MARKET GROWTH 336
11.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 336
11.6.3 GCC COUNTRIES 342
11.6.3.1 Rising healthcare investments to fuel uptake 342
11.6.4 REST OF MIDDLE EAST & AFRICA 347
12 COMPETITIVE LANDSCAPE 353
12.1 OVERVIEW 353
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 353
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CLINICAL INFORMATICS MARKET 354
12.3 REVENUE ANALYSIS, 2019–2023 358
12.4 MARKET SHARE ANALYSIS, 2023 359
12.5 COMPANY VALUATION AND FINANCIAL METRICS 362
12.6 BRAND/SOFTWARE COMPARISON 364
12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 365
12.7.1 STARS 365
12.7.2 EMERGING LEADERS 365
12.7.3 PERVASIVE PLAYERS 365
12.7.4 PARTICIPANTS 365
12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 367
12.7.5.1 Company footprint 367
12.7.5.2 Region footprint 368
12.7.5.3 Function footprint 369
12.7.5.4 Component footprint 374
12.7.5.5 Deployment model footprint 375
12.7.5.6 End-user footprint 376
 
12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 377
12.8.1 PROGRESSIVE COMPANIES 377
12.8.2 RESPONSIVE COMPANIES 377
12.8.3 DYNAMIC COMPANIES 377
12.8.4 STARTING BLOCKS 377
12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 379
12.8.5.1 Detailed list of key startups/SMEs 379
12.8.5.2 Competitive benchmarking of startups/SMEs 380
12.9 COMPETITIVE SCENARIO 380
12.9.1 PRODUCT LAUNCHES/APPROVALS/UPGRADES 380
12.9.2 DEALS 383
12.9.3 EXPANSIONS 385
12.9.4 OTHER DEVELOPMENTS 386
13 COMPANY PROFILES 387
13.1 KEY PLAYERS 387
13.1.1 UNITEDHEALTH GROUP 387
13.1.1.1 Business overview 387
13.1.1.2 Products offered 388
13.1.1.3 Recent developments 391
13.1.1.3.1 Product launches/approvals/upgrades 391
13.1.1.3.2 Deals 391
13.1.1.4 MnM view 392
13.1.1.4.1 Right to win 392
13.1.1.4.2 Strategic choices 392
13.1.1.4.3 Weaknesses and competitive threats 392
13.1.2 ORACLE 393
13.1.2.1 Business overview 393
13.1.2.2 Products offered 395
13.1.2.3 Recent developments 398
13.1.2.3.1 Product launches/approvals/upgrades 398
13.1.2.3.2 Deals 400
13.1.2.3.3 Contracts 401
13.1.2.4 MnM view 402
13.1.2.4.1 Right to win 402
13.1.2.4.2 Strategic choices 402
13.1.2.4.3 Weaknesses and competitive threats 402
13.1.3 EPIC SYSTEMS CORPORATION 402
13.1.3.1 Business overview 402
13.1.3.2 Products offered 403
13.1.3.3 Recent developments 408
13.1.3.3.1 Product launches/approvals/upgrades 408
13.1.3.3.2 Deals 409
13.1.3.3.3 Contracts 410
13.1.3.4 MnM view 411
13.1.3.4.1 Right to win 411
13.1.3.4.2 Strategic choices 411
13.1.3.4.3 Weaknesses and competitive threats 411
13.1.4 KONINKLIJKE PHILIPS N.V. 412
13.1.4.1 Business overview 412
13.1.4.2 Products offered 414
13.1.4.3 Recent developments 416
13.1.4.3.1 Product launches/approvals/upgrades 416
13.1.4.3.2 Deals 417
13.1.4.4 MnM view 423
13.1.4.4.1 Right to win 423
13.1.4.4.2 Strategic choices 423
13.1.4.4.3 Weaknesses and competitive threats 423
13.1.5 MCKESSON CORPORATION 424
13.1.5.1 Business overview 424
13.1.5.2 Products offered 425
13.1.5.3 Recent developments 427
13.1.5.3.1 Deals 427
13.1.5.3.2 Expansions 428
13.1.5.4 MnM view 428
13.1.5.4.1 Right to win 428
13.1.5.4.2 Strategic choices 428
13.1.5.4.3 Weaknesses and competitive threats 429
13.1.6 GE HEALTHCARE 430
13.1.6.1 Business overview 430
13.1.6.2 Products offered 432
13.1.6.3 Recent developments 434
13.1.6.3.1 Product launches/approvals/upgrades 434
13.1.6.3.2 Deals 435
13.1.7 COGNIZANT 437
13.1.7.1 Business overview 437
13.1.7.2 Products offered 439
13.1.7.3 Recent developments 439
13.1.7.3.1 Product launches/approvals/upgrades 439
13.1.7.3.2 Deals 440
13.1.8 EXLSERVICE HOLDINGS, INC. 441
13.1.8.1 Business overview 441
13.1.8.2 Products offered 443
13.1.8.3 Recent developments 445
13.1.8.3.1 Deals 445
13.1.9 ECLINICALWORKS 446
13.1.9.1 Business overview 446
13.1.9.2 Products offered 446
13.1.9.3 Recent developments 448
13.1.9.3.1 Product launches/approvals/upgrades 448
13.1.9.3.2 Deals 448
13.1.10 MEDICAL INFORMATION TECHNOLOGY, INC. 450
13.1.10.1 Business overview 450
13.1.10.2 Products offered 450
13.1.10.3 Recent developments 451
13.1.10.3.1 Product launches/approvals/upgrades 451
13.1.10.3.2 Deals 452
13.1.10.3.3 Contracts 453
13.1.10.3.4 Other developments 455
13.1.11 SIEMENS HEALTHINEERS AG 456
13.1.11.1 Business overview 456
13.1.11.2 Products offered 458
13.1.11.3 Recent developments 459
13.1.11.3.1 Product launches/approvals/upgrades 459
13.1.11.3.2 Deals 459
13.1.12 TRUBRIDGE 462
13.1.12.1 Business overview 462
13.1.12.2 Products offered 464
13.1.12.3 Recent developments 465
13.1.12.3.1 Product launches/approvals/upgrades 465
13.1.12.3.2 Deals 465
13.1.12.3.3 Other developments 466
13.1.13 VERADIGM LLC 467
13.1.13.1 Business overview 467
13.1.13.2 Products offered 469
13.1.13.3 Recent developments 470
13.1.13.3.1 Deals 470
13.1.14 ADVANCEDMD, INC. 471
13.1.14.1 Business overview 471
13.1.14.2 Products offered 472
13.1.14.3 Recent developments 473
13.1.14.3.1 Product launches/approvals/upgrades 473
13.1.14.3.2 Other developments 474
 
13.1.15 ATHENAHEALTH, INC. 475
13.1.15.1 Business overview 475
13.1.15.2 Products offered 475
13.1.15.3 Recent developments 476
13.1.15.3.1 Product launches/approvals/upgrades 476
13.1.15.3.2 Deals 477
13.1.15.3.3 Contracts 479
13.1.16 MERATIVE 481
13.1.16.1 Business overview 481
13.1.16.2 Products offered 482
13.1.16.3 Recent developments 483
13.1.16.3.1 Product launches/approvals/upgrades 483
13.1.16.3.2 Deals 484
13.1.16.3.3 Other developments 484
13.1.17 NVIDIA CORPORATION 485
13.1.17.1 Business overview 485
13.1.17.2 Products offered 487
13.1.17.3 Recent developments 488
13.1.17.3.1 Product launches/approvals/upgrades 488
13.1.17.3.2 Deals 488
13.1.18 AGFA HEALTHCARE 490
13.1.18.1 Business overview 490
13.1.18.2 Products offered 490
13.1.18.3 Recent developments 491
13.1.18.3.1 Product launches/approvals/upgrades 491
13.1.18.3.2 Deals 491
13.1.19 NXGN MANAGEMENT, LLC 492
13.1.19.1 Business overview 492
13.1.19.2 Products offered 492
13.1.19.3 Recent developments 493
13.1.19.3.1 Product launches/approvals/upgrades 493
13.1.19.3.2 Deals 494
13.1.19.3.3 Expansions 495
13.1.19.3.4 Contracts 496
13.1.20 INTERSYSTEMS CORPORATION 498
13.1.20.1 Business overview 498
13.1.20.2 Products offered 499
13.1.20.3 Recent developments 500
13.1.20.3.1 Product launches/approvals/upgrades 500
13.1.20.3.2 Deals 501
 
13.1.21 DEDALUS S.P.A. 502
13.1.21.1 Business overview 502
13.1.21.2 Products offered 502
13.1.21.3 Recent developments 503
13.1.21.3.1 Deals 503
13.1.22 IQVIA INC. 505
13.1.22.1 Business overview 505
13.1.22.2 Products offered 507
13.1.22.3 Recent developments 508
13.1.22.3.1 Product launches/approvals/upgrades 508
13.1.23 SAS INSTITUTE INC. 509
13.1.23.1 Business overview 509
13.1.23.2 Products offered 509
13.1.23.3 Recent developments 510
13.1.23.3.1 Product launches/approvals/upgrades 510
13.1.23.3.2 Deals 510
13.1.24 WIPRO 511
13.1.24.1 Business overview 511
13.1.24.2 Products offered 513
13.1.24.3 Recent developments 514
13.1.24.3.1 Deals 514
13.1.25 HEALTH CATALYST 515
13.1.25.1 Business overview 515
13.1.25.2 Products offered 516
13.1.25.3 Recent developments 517
13.1.25.3.1 Deals 517
13.2 OTHER PLAYERS 518
13.2.1 TEMPUS 518
13.2.2 PRACTICE FUSION, INC. 519
13.2.3 MEDEANALYTICS, INC. 520
13.2.4 MEDECISION 521
13.2.5 CHARTIS 522
13.2.6 ALLARA HEALTH 523
13.2.7 SURGICAL INFORMATION SYSTEMS 524
13.2.8 ANUMANA, INC. 525
13.2.9 MEMORA HEALTH INC. 526
13.2.10 MEDIVIEW XR, INC. 527
 
14 APPENDIX 528
14.1 DISCUSSION GUIDE 528
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 534
14.3 CUSTOMIZATION OPTIONS 536
14.4 RELATED REPORTS 537
14.5 AUTHOR DETAILS 538